PACKAGE LEAFLET: INFORMATION FOR THE USER
Physiological serum 0.9% Vantive (Clear-Flex) solution for infusion
Active ingredient: sodium chloride
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is called “Physiological serum 0.9% Vantive (Clear-Flex) solution for infusion” but will be referred to as Physiological serum 0.9% throughout the rest of this leaflet.
Contents of the pack:
Physiological serum 0.9% is a solution of sodium chloride in water. Sodium chloride is a chemical substance (commonly called salt) that is found in the blood.
Physiological serum 0.9% is used to treat:
The situations that can cause loss of water and sodium include:
Physiological serum 0.9% can also be used to administer or dilute other medicines for infusion.
YOU WILL NOT BE GIVEN Physiological serum 0.9% IF YOU HAVE ANY OF THE FOLLOWING MEDICAL CONDITIONS:
If another medicine has been added to Physiological serum 0.9%, you should consult its package leaflet to determine if you can receive the solution.
Warnings and precautions
Tell your doctor or nurse if you have or have had any of the following medical conditions:
When you are being given this solution, your doctor may take blood and urine samples to check:
This is especially important in children and babies (premature babies), as they may retain too much sodium due to their immature kidney function.
Your doctor will consider whether you are receiving parenteral nutrition (nutrition given by infusion into a vein). During prolonged treatment with Physiological serum 0.9%, you may need to receive extra nutrition.
Other medicines and Physiological serum 0.9%
Tell your doctor or nurse if you are using, have recently used, or might use any other medicines.
It is especially important that you tell your doctor if you are taking:
These medicines can cause the body to retain sodium and water, leading to tissue inflammation due to fluid accumulation under the skin (edema) and high blood pressure (hypertension).
cholesterol medication (clofibrate)
Using Physiological serum 0.9% with food and drinks
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Ask your doctor or nurse for advice before driving or using machines.
Physiological serum 0.9% will be given to you by a doctor or nurse. Your doctor will decide how much you need and when you will be given it. This will depend on your age, weight, medical condition, the reason for your treatment, and whether the infusion is used to administer or dilute another medicine.
The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Physiological serum 0.9% if there are particles floating in the solution or if the container is damaged in any way.
Physiological serum 0.9% is usually given to you through a plastic tube connected to a needle in a vein, almost always in your arm; however, your doctor may use another method to administer the medicine.
Before and during the infusion, your doctor will check:
Any unused solution should be discarded. You MUST NOT receive Physiological serum 0.9% from a bag that has been used partially.
If you receive more Physiological serum 0.9% than you should
If you are given too much Physiological serum 0.9% (overdose), the following symptoms may occur:
If you notice any of these symptoms, you should inform your doctor immediately. Your infusion will be stopped and you will be treated depending on the symptoms.
If another medicine has been added to Physiological serum 0.9% before the overdose, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you stop the infusion of Physiological serum 0.9%
Your doctor will decide whether you should stop receiving this infusion.
If you have any further questions about the use of this product, ask your doctor or nurse.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 915.620.420
Like all medicines, this medicine can cause side effects, although not everybody gets them. The frequency of these effects is unknown.
Low sodium levels in the blood that can be acquired during hospitalization (hospital-acquired hyponatremia) and related neurological disorder (acute hyponatremic encephalopathy).
Side effects that may occur due to the administration technique include:
Other side effects that have been reported with similar products (other solutions containing sodium) include:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
If any of these occur, the infusion must be stopped.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
DO NOT use this medicine after the expiry date which is stated on the bag after EXP. The expiry date is the last day of the month shown.
You MUST NOT receive this medicine if there are particles floating in the solution or if the container is damaged in any way.
Composition of 0.9% Sodium Chloride Solution
The active ingredient is sodium chloride: 9 g per liter.
The only excipient is water for injectable preparations.
Appearance of the Product and Container Contents
0.9% Sodium Chloride Solution is a clear, particle-free solution. It is presented in polypropylene/polyamide/polyethylene plastic bags (Clear-Flex). Each bag is packaged in a sealed protective plastic overbag.
The bag sizes are:
The bags are supplied in boxes, each containing the following quantities:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Vantive Health, S.L.
Polígono Industrial Sector 14
C/Pouet de Camilo 2
46394 Ribarroja del Turia (Valencia) Spain
Manufacturer:
Bieffe Medital S.p.A.
Via Nuova Provinciale
I-23034 Grosotto (SO)
Italy
Date of Last Revision of this Leaflet: November 2018
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
-------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free of visible particles, and the container is intact. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the sterility of the solution.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air dragged from the primary container before the administration of the liquid contained in the secondary container is completed.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to gas embolism if the residual air in the container is not fully evacuated before administration.
The solution must be administered with sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air from entering the system.
When adding medications, verify isotonicity before parenteral administration. Complete and careful aseptic mixing of any medication is necessary. Solutions containing medications should be used immediately and not stored.
The addition of other medications or the use of incorrect administration techniques can cause the appearance of febrile reactions due to the possible introduction of pyrogens. In the event of an adverse reaction, the infusion should be interrupted immediately.
Discard after a single use.
Discard any remaining portion.
Do not reconnect partially used bags.
Use sterile material for preparation and administration.
Warning: Added medications may be incompatible. (See section 5 "Incompatibilities of Added Medications" below)
To Add Medication Before Administration
Precaution: Do not store bags with added medication.
To Add Medication During Administration
Before use, the physical and chemical stability of any added medication must be established at the pH of the 0.9% Sodium Chloride Solution in the Clear-Flex bag.
From a microbiological point of view, the diluted product must be used immediately unless the addition of medications has been carried out under aseptic and validated conditions. If not used immediately, the conditions and storage times used before use are the responsibility of the user.
As with all parenteral solutions, the incompatibility of added medications to the solution in the Clear-Flex bag must be verified before addition.
In the absence of compatibility studies, this solution should not be mixed with other medications.
It is the responsibility of the physician to judge the incompatibility of the added medication to 0.9% Sodium Chloride Solution by examining any eventual change in color and/or precipitate, appearance of insoluble complexes or crystals. The leaflet of the medication to be added should be consulted.
Before adding a medication, verify that it is soluble and stable in water at the pH of 0.9% Sodium Chloride Solution.
Medications known to be incompatible should not be used.